Boring Factual Information About AFFO For American Tower

Summary:

  • Sorry, no jokes in this one. Just running the numbers publicly.
  • I wasn’t going to send this to the public side, but I think discussions about AFFO make it important for investors to have the right context.
  • AFFO per share growth from 2022 to 2023 looks bad because of non-recurring headwinds. These issues occurred together and resulted in a significant decline in AFFO’s projected figures for the year.

Scientific breakthrough

Math is important

Imgorthand

One of the most important lessons for equity REIT investors to understand is that long-term AFFO is primarily (not exclusively!) driven by real estate. The performance for shareholders can be aided or hampered by changes in interest rates


Analyst’s Disclosure: I/we have a beneficial long position in the shares of AMT, CCI, SBAC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Our analysis is better than what the underwriters did before risking over $140 million. Might be a good idea to try it. How do you think we kept beating the indexes? Due diligence.

It’s not 50% off. We don’t do that. Things that are often “50% off” just have an inflated sticker price to convince people they are getting a deal. Great research at a fair price. It’s better than poor research at a discounted price.

Click the link to get your two-week trial

Leave a Reply

Your email address will not be published. Required fields are marked *